Novartis Gene Therapies develops and commercializes gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The Durham site is Novartis Gene Therapies' manufacturing operations.
Company Location
2500 S. Tri-Center Blvd.
Durham
NC
27713
County
Region
Company Details
Year founded
2013
Employment range in NC
US headquarters
Illinois
Global headquarters
Switzerland
Primary site activity
All company activities
Core capabilities
Potential end market(s)
Products on market
Zolgensma (AVXS-101) a gene therapy product for the treatment of spinal muscular atrophy